**Question:** Beta-adrenoceptor blocking agent that should be avoided in patients with renal failure is:

A. Propranolol
B. Attenuated androgens (fludrocortisone)
C. Salbutamol
D. Salmeterol

**Core Concept:**
Renal failure refers to a condition where the kidneys lose their ability to filter waste products from the blood effectively. In patients with renal failure, the clearance of certain medications is impaired, leading to increased drug levels and potential adverse effects. Beta-adrenergic blockers are medications that block the effects of adrenaline and noradrenaline on beta-adrenoceptors, which are involved in regulating heart rate, blood pressure, and cardiac output.

**Why the Correct Answer is Right:**
Propranolol is a non-selective beta-blocker, meaning it blocks both beta-1 and beta-2 receptors. In renal failure, the clearance of propranolol is significantly reduced, leading to higher propranolol levels and potentially decreased cardiac output, worsening the patient's condition.

**Why Each Wrong Option is Incorrect:**
Attenuated androgens (fludrocortisone): Fludrocortisone is a corticosteroid used to treat hyponatremia and hypokalemia in patients with congestive heart failure or renal failure. It does not interfere with the clearance of other medications and is generally safe in renal failure.

Salbutamol (salmeterol): Salbutamol and salmeterol are short-acting beta-agonists used for bronchodilation in asthma and other respiratory conditions. Both are selective beta-2 agonists, meaning they primarily affect beta-2 receptors and have less impact on cardiac output compared to non-selective beta-blockers. However, they are not specifically mentioned in the question, so they are considered incorrect due to the focus on beta-blockers.

**Clinical Pearl:**
In patients with renal failure, it is essential to consider the pharmacokinetics and pharmacodynamics of medications to ensure appropriate therapy. Non-selective beta-blockers like propranolol should be avoided due to impaired clearance, while selective beta-agonists like salbutamol and salmeterol are generally safer.